Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: A4HI22
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 12 |
GO:0008684 | 2-oxopent-4-enoate hydratase activity | 5 | 1 |
GO:0016829 | lyase activity | 2 | 1 |
GO:0016835 | carbon-oxygen lyase activity | 3 | 1 |
GO:0016836 | hydro-lyase activity | 4 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 125 | 129 | PF00656 | 0.363 |
CLV_NRD_NRD_1 | 95 | 97 | PF00675 | 0.424 |
CLV_PCSK_KEX2_1 | 180 | 182 | PF00082 | 0.579 |
CLV_PCSK_PC1ET2_1 | 180 | 182 | PF00082 | 0.554 |
CLV_PCSK_SKI1_1 | 118 | 122 | PF00082 | 0.355 |
CLV_PCSK_SKI1_1 | 188 | 192 | PF00082 | 0.483 |
CLV_PCSK_SKI1_1 | 222 | 226 | PF00082 | 0.424 |
CLV_PCSK_SKI1_1 | 230 | 234 | PF00082 | 0.423 |
DEG_APCC_DBOX_1 | 1 | 9 | PF00400 | 0.532 |
DEG_Nend_UBRbox_1 | 1 | 4 | PF02207 | 0.630 |
DOC_CKS1_1 | 207 | 212 | PF01111 | 0.449 |
DOC_CKS1_1 | 241 | 246 | PF01111 | 0.378 |
DOC_PP4_FxxP_1 | 150 | 153 | PF00568 | 0.357 |
DOC_USP7_MATH_1 | 228 | 232 | PF00917 | 0.443 |
DOC_USP7_UBL2_3 | 225 | 229 | PF12436 | 0.489 |
DOC_WW_Pin1_4 | 135 | 140 | PF00397 | 0.386 |
DOC_WW_Pin1_4 | 206 | 211 | PF00397 | 0.395 |
DOC_WW_Pin1_4 | 237 | 242 | PF00397 | 0.323 |
LIG_14-3-3_CanoR_1 | 188 | 198 | PF00244 | 0.495 |
LIG_14-3-3_CanoR_1 | 2 | 6 | PF00244 | 0.547 |
LIG_14-3-3_CanoR_1 | 259 | 265 | PF00244 | 0.454 |
LIG_14-3-3_CanoR_1 | 96 | 100 | PF00244 | 0.493 |
LIG_deltaCOP1_diTrp_1 | 253 | 257 | PF00928 | 0.382 |
LIG_FHA_1 | 185 | 191 | PF00498 | 0.471 |
LIG_FHA_1 | 259 | 265 | PF00498 | 0.444 |
LIG_FHA_1 | 80 | 86 | PF00498 | 0.343 |
LIG_LIR_Gen_1 | 208 | 219 | PF02991 | 0.438 |
LIG_LIR_Gen_1 | 261 | 266 | PF02991 | 0.451 |
LIG_LIR_Nem_3 | 146 | 151 | PF02991 | 0.373 |
LIG_LIR_Nem_3 | 17 | 21 | PF02991 | 0.435 |
LIG_LIR_Nem_3 | 208 | 214 | PF02991 | 0.436 |
LIG_LIR_Nem_3 | 253 | 257 | PF02991 | 0.407 |
LIG_LIR_Nem_3 | 261 | 265 | PF02991 | 0.346 |
LIG_LIR_Nem_3 | 58 | 64 | PF02991 | 0.421 |
LIG_LYPXL_yS_3 | 61 | 64 | PF13949 | 0.359 |
LIG_Pex14_2 | 90 | 94 | PF04695 | 0.316 |
LIG_SH2_CRK | 262 | 266 | PF00017 | 0.352 |
LIG_SH2_STAP1 | 220 | 224 | PF00017 | 0.336 |
LIG_SH2_STAP1 | 250 | 254 | PF00017 | 0.436 |
LIG_SH2_STAP1 | 3 | 7 | PF00017 | 0.402 |
LIG_SH2_STAT3 | 21 | 24 | PF00017 | 0.491 |
LIG_SH2_STAT5 | 108 | 111 | PF00017 | 0.377 |
LIG_SH2_STAT5 | 18 | 21 | PF00017 | 0.374 |
LIG_SH3_3 | 238 | 244 | PF00018 | 0.378 |
LIG_SH3_3 | 65 | 71 | PF00018 | 0.300 |
LIG_SH3_3 | 82 | 88 | PF00018 | 0.322 |
LIG_SH3_5 | 14 | 18 | PF00018 | 0.250 |
LIG_Sin3_3 | 211 | 218 | PF02671 | 0.427 |
LIG_TRAF2_1 | 55 | 58 | PF00917 | 0.368 |
LIG_TYR_ITIM | 260 | 265 | PF00017 | 0.364 |
LIG_UBA3_1 | 89 | 97 | PF00899 | 0.376 |
MOD_CDK_SPK_2 | 237 | 242 | PF00069 | 0.328 |
MOD_CK1_1 | 131 | 137 | PF00069 | 0.402 |
MOD_CK1_1 | 175 | 181 | PF00069 | 0.418 |
MOD_CK1_1 | 183 | 189 | PF00069 | 0.377 |
MOD_CK1_1 | 240 | 246 | PF00069 | 0.348 |
MOD_CK2_1 | 28 | 34 | PF00069 | 0.489 |
MOD_GlcNHglycan | 142 | 146 | PF01048 | 0.403 |
MOD_GlcNHglycan | 201 | 204 | PF01048 | 0.382 |
MOD_GlcNHglycan | 211 | 214 | PF01048 | 0.330 |
MOD_GlcNHglycan | 8 | 11 | PF01048 | 0.619 |
MOD_GSK3_1 | 131 | 138 | PF00069 | 0.361 |
MOD_GSK3_1 | 166 | 173 | PF00069 | 0.371 |
MOD_GSK3_1 | 180 | 187 | PF00069 | 0.398 |
MOD_GSK3_1 | 75 | 82 | PF00069 | 0.429 |
MOD_NEK2_1 | 1 | 6 | PF00069 | 0.485 |
MOD_NEK2_1 | 141 | 146 | PF00069 | 0.385 |
MOD_NEK2_1 | 184 | 189 | PF00069 | 0.378 |
MOD_NEK2_1 | 260 | 265 | PF00069 | 0.364 |
MOD_NEK2_1 | 48 | 53 | PF00069 | 0.444 |
MOD_NEK2_1 | 79 | 84 | PF00069 | 0.444 |
MOD_NEK2_1 | 8 | 13 | PF00069 | 0.439 |
MOD_NEK2_2 | 228 | 233 | PF00069 | 0.259 |
MOD_NEK2_2 | 75 | 80 | PF00069 | 0.486 |
MOD_PIKK_1 | 79 | 85 | PF00454 | 0.389 |
MOD_PK_1 | 170 | 176 | PF00069 | 0.246 |
MOD_PK_1 | 97 | 103 | PF00069 | 0.432 |
MOD_PKA_1 | 180 | 186 | PF00069 | 0.402 |
MOD_PKA_2 | 1 | 7 | PF00069 | 0.576 |
MOD_PKA_2 | 180 | 186 | PF00069 | 0.402 |
MOD_PKA_2 | 258 | 264 | PF00069 | 0.429 |
MOD_PKA_2 | 79 | 85 | PF00069 | 0.334 |
MOD_PKA_2 | 95 | 101 | PF00069 | 0.346 |
MOD_Plk_1 | 122 | 128 | PF00069 | 0.496 |
MOD_Plk_2-3 | 123 | 129 | PF00069 | 0.482 |
MOD_Plk_2-3 | 28 | 34 | PF00069 | 0.512 |
MOD_Plk_4 | 228 | 234 | PF00069 | 0.358 |
MOD_Plk_4 | 260 | 266 | PF00069 | 0.387 |
MOD_ProDKin_1 | 135 | 141 | PF00069 | 0.384 |
MOD_ProDKin_1 | 206 | 212 | PF00069 | 0.394 |
MOD_ProDKin_1 | 237 | 243 | PF00069 | 0.323 |
TRG_DiLeu_BaEn_1 | 116 | 121 | PF01217 | 0.367 |
TRG_DiLeu_BaLyEn_6 | 3 | 8 | PF01217 | 0.423 |
TRG_DiLeu_BaLyEn_6 | 59 | 64 | PF01217 | 0.373 |
TRG_ENDOCYTIC_2 | 262 | 265 | PF00928 | 0.342 |
TRG_ENDOCYTIC_2 | 61 | 64 | PF00928 | 0.468 |
TRG_Pf-PMV_PEXEL_1 | 118 | 122 | PF00026 | 0.355 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I7W6 | Leptomonas seymouri | 65% | 100% |
A0A0S4KNC9 | Bodo saltans | 24% | 100% |
A0A1X0P382 | Trypanosomatidae | 40% | 100% |
A0A3Q8IFI2 | Leishmania donovani | 91% | 100% |
A0A422NIG2 | Trypanosoma rangeli | 38% | 100% |
A4I599 | Leishmania infantum | 91% | 100% |
C9ZQN0 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 38% | 100% |
E9B0J5 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 90% | 100% |
Q4Q7N7 | Leishmania major | 90% | 100% |
Q584U2 | Trypanosoma brucei brucei (strain 927/4 GUTat10.1) | 38% | 100% |
V5BC65 | Trypanosoma cruzi | 37% | 100% |